Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.34 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.34 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.34 |
| ▸ | FAP | Q12884 | 1/20 | 0.34 |
| ▸ | CTSV | O60911 | 2/20 | 0.34 |
| ▸ | CTSS | P25774 | 2/20 | 0.34 |
| ▸ | CTSK | P43235 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 2/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | CMA1 | P23946 | 1/20 | 0.33 |
| ▸ | CTSF | Q9UBX1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25271187 | 0.88 | DPP4 (0.36) | DPP4DPP8DPP9DPP7FAP | |
| Trifluoroacetic Acid SCHEMBL29894802 | 0.85 | DPP4 (0.35) | DPP4DPP8DPP7CTSVCTSS | |
| Trifluoroacetic Acid SCHEMBL27076720 | 0.83 | DPP4 (0.37) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL24209768 | 0.82 | DPP4 (0.39) | DPP4DPP8DPP9DPP7FAP | |
| Hydrochloric Acid SCHEMBL29609105 | 0.81 | DPP4 (0.38) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL24425133 | 0.79 | DPP4 (0.40) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL26119474 | 0.79 | DPP4 (0.40) | DPP4DPP8DPP9DPP7FAP | |
| Hydrochloric Acid SCHEMBL29609065 | 0.78 | DPP4 (0.40) | DPP4DPP8DPP9DPP7FAP | |
| Hydrochloric Acid SCHEMBL26117750 | 0.78 | DPP4 (0.40) | DPP4DPP8DPP9DPP7FAP | |
| Trifluoroacetic Acid SCHEMBL30489482 | 0.73 | CTSV (0.37) | DPP4DPP8DPP9CTSVCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4313305-A1 | SARS-COV-2 MPRO INHIBITOR COMPOUNDS | Heptares Therapeutics Limited (GB) | 2024-02-07 | — | — | EP | disclosed |